{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:30:24Z","timestamp":1790605824833,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijid.2026.108502","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:58:22Z","timestamp":1772207902000},"page":"108502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Invasive meningococcal disease rebound in older adults post-COVID-19 pandemic: A targeted literature and surveillance review"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3380-7092","authenticated-orcid":false,"given":"Saber","family":"Yezli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakker","family":"Divyesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ijid.2026.108502_bib0001","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108502_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fped.2018.00321","article-title":"Invasive meningococcal disease in the vaccine era","volume":"6","author":"Nadel","year":"2018","journal-title":"Front Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2026.108502_bib0003","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijid.2026.108502_bib0004","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12889-022-12933-3","article-title":"Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017\u2014a secondary database analysis","volume":"22","author":"Guedes","year":"2022","journal-title":"BMC Public Health"},{"issue":"21","key":"10.1016\/j.ijid.2026.108502_bib0005","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ijid.2026.108502_bib0006","doi-asserted-by":"crossref","first-page":"e582","DOI":"10.1016\/S2589-7500(23)00108-5","article-title":"Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS consortium","volume":"5","author":"Shaw","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"5","key":"10.1016\/j.ijid.2026.108502_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2023.09.002","article-title":"Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England","volume":"87","author":"Clark","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.108502_bib0008","series-title":"Invasive meningococcal disease\u2014annual epidemiological report for 2022","year":"2024"},{"issue":"3","key":"10.1016\/j.ijid.2026.108502_bib0009","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jinf.2019.12.008","article-title":"Invasive meningococcal disease: timing and cause of death in England, 2008-2015","volume":"80","author":"Beebeejaun","year":"2020","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.ijid.2026.108502_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"},{"issue":"12","key":"10.1016\/j.ijid.2026.108502_bib0011","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s40121-024-01063-5","article-title":"Global epidemiology of meningococcal disease-causing serogroups before and after the COVID-19 pandemic: a narrative review","volume":"13","author":"Shen","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijid.2026.108502_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ijid.2026.108502_bib0013","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jiph.2023.10.001","article-title":"The rapid rebound of invasive meningococcal disease in France at the end of 2022","volume":"16","author":"Taha","year":"2023","journal-title":"J Infect Public Health"},{"issue":"2","key":"10.1016\/j.ijid.2026.108502_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.32394\/pe\/191221","article-title":"Meningitis and encephalitis in Poland in 2022","volume":"78","author":"Mrozowska-Nyckowska","year":"2024","journal-title":"Przegl Epidemiol"},{"issue":"3","key":"10.1016\/j.ijid.2026.108502_bib0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.32394\/pe.77.35","article-title":"Meningitis and encephalitis in Poland in 2021","volume":"77","author":"Mrozowska-Nyckowska","year":"2023","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.ijid.2026.108502_bib0016","series-title":"Annual epidemiological report for 2018","article-title":"Invasive meningococcal disease","year":"2022"},{"key":"10.1016\/j.ijid.2026.108502_bib0017","series-title":"Invasive meningococcal disease in England: annual report for 2020 to 2021","year":"2021"},{"key":"10.1016\/j.ijid.2026.108502_bib0018","series-title":"Annual epidemiological report for 2021","article-title":"Invasive meningococcal disease","year":"2023"},{"key":"10.1016\/j.ijid.2026.108502_bib0019","unstructured":"European Centre for Disease Prevention and Control Surveillance atlas of infectious diseases. Stockholm: ECDC. https:\/\/ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases, [accessed June 2024]."},{"key":"10.1016\/j.ijid.2026.108502_bib0020","series-title":"Infections Invasives \u00e0 M\u00e9ningocoque en France: Bilan Annuel 2020","year":"2021"},{"key":"10.1016\/j.ijid.2026.108502_bib0021","series-title":"Infections Invasives \u00e0 M\u00e9ningocoque en France: bilan Annuel 2021","year":"2022"},{"key":"10.1016\/j.ijid.2026.108502_bib0022","series-title":"Infections Invasives \u00e0 M\u00e9ningocoque en France: Bilan Annuel 2022","year":"2023"},{"key":"10.1016\/j.ijid.2026.108502_bib0023","unstructured":"Instituto de Salud Carlos III. Bolet\u00edn Epidemiol\u00f3gico Semanal. Madrid: ISCIII. https:\/\/revista.isciii.es\/index.php\/bes\/, [accessed June 2024]."},{"key":"10.1016\/j.ijid.2026.108502_bib0024","series-title":"Infectious disease epidemiology yearbook of notifiable diseases for 2022","year":"2022"},{"key":"10.1016\/j.ijid.2026.108502_bib0025","series-title":"National surveillance of invasive bacterial diseases: 2019\u20132021","year":"2021"},{"key":"10.1016\/j.ijid.2026.108502_bib0026","series-title":"Sorveglianza nazionale delle malattie batteriche invasive. Dati 2021\u20132023","author":"Fazio","year":"2024"},{"key":"10.1016\/j.ijid.2026.108502_bib0027","series-title":"Invasive meningococcal disease in England: annual laboratory confirmed reports for epidemiological year 2022 to 2023","year":"2023"},{"key":"10.1016\/j.ijid.2026.108502_bib0028","unstructured":"Adriaansens DLL, Beninc\u00e0 E, Benschop KSM, van Benthem BHB, Berry DSF et al. The National Immunisation Programme in the Netherlands, surveillance and developments in 2023\u20132024, RIVM report 2024-0072. https:\/\/rivm.openrepository.com\/entities\/publication\/f1edb712-d85a-4cf8-83dc-ad71fe66490d, [accessed June 2024]."},{"key":"10.1016\/j.ijid.2026.108502_bib0029","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease surveillance and trends. https:\/\/www.cdc.gov\/meningococcal\/php\/surveillance\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html, [accessed June 2024]."},{"key":"10.1016\/j.ijid.2026.108502_bib0030","series-title":"Enhanced meningococcal disease surveillance report, 2018: confirmed and probable cases reported to the National Notifiable Diseases Surveillance System","year":"2019"},{"key":"10.1016\/j.ijid.2026.108502_bib0031","series-title":"Enhanced meningococcal disease surveillance report, 2019: confirmed and probable cases reported to the National Notifiable Diseases Surveillance System","year":"2020"},{"key":"10.1016\/j.ijid.2026.108502_bib0032","series-title":"Enhanced meningococcal disease surveillance report, 2020: confirmed and probable cases reported to the National Notifiable Diseases Surveillance System","year":"2021"},{"key":"10.1016\/j.ijid.2026.108502_bib0033","series-title":"Enhanced meningococcal disease surveillance report, 2021: confirmed and probable cases reported to the National Notifiable Diseases Surveillance System","year":"2022"},{"key":"10.1016\/j.ijid.2026.108502_bib0034","series-title":"Enhanced meningococcal disease surveillance report, 2022: confirmed and probable cases reported to the National Notifiable Diseases Surveillance System","year":"2023"},{"issue":"9","key":"10.1016\/j.ijid.2026.108502_bib0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.14745\/ccdr.v49i09a01","article-title":"A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure","volume":"49","author":"Pham-Huy","year":"2023","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.ijid.2026.108502_bib0036","year":"2023","journal-title":"National notifiable disease surveillance dashboard"},{"key":"10.1016\/j.ijid.2026.108502_bib0037","article-title":"Meningococcal\u2014Australian meningococcal surveillance programme annual report, 2023","volume":"48","year":"2024","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.ijid.2026.108502_bib0038","article-title":"Australian meningococcal surveillance programme annual report, 2019","volume":"44","author":"Lahra","year":"2020","journal-title":"Commun Dis Intell (2018)"},{"key":"10.1016\/j.ijid.2026.108502_bib0039","article-title":"Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis","volume":"375","author":"Talic","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ijid.2026.108502_bib0040","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1093\/cid\/ciaa1733","article-title":"Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: a systematic review and meta-analysis","volume":"73","author":"McMillan","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108502_bib0041","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s12879-024-09547-y","article-title":"Recent increase in atypical presentations of invasive meningococcal disease in France","volume":"24","author":"Taha","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108502_bib0042","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/20477724.2021.1972663","article-title":"Evolving strategies for meningococcal vaccination in Europe: overview and key determinants for current and future considerations","volume":"116","author":"Martin\u00f3n-Torres","year":"2022","journal-title":"Pathog Glob Health"},{"issue":"5","key":"10.1016\/j.ijid.2026.108502_bib0043","doi-asserted-by":"crossref","DOI":"10.4161\/hv.20098","article-title":"Increase of meningococcal serogroup Y cases in Europe: a reason for concern?","volume":"8","author":"Br\u00f6ker","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.ijid.2026.108502_bib0044","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s40121-023-00869-z","article-title":"Range of clinical manifestations caused by invasive meningococcal disease due to serogroup W: a systematic review","volume":"12","author":"Bertrand-Gerentes","year":"2023","journal-title":"Infect Dis Ther"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:19:08Z","timestamp":1777609148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226001372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"alternative-id":["S1201971226001372"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108502","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive meningococcal disease rebound in older adults post-COVID-19 pandemic: A targeted literature and surveillance review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108502"}}